Physician profile
Michael G Browne
NPI 1992730980
$5,050.04
in general payments reported to CMS, 2019-2025
15 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $1,501 · 2021: $200 · 2022: $444 · 2023: $1,247 · 2024: $89.80 · 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,145 · Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,145.22 |
| Food and Beverage | $386.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $1,377.22 | 2019-2022 | |
| Anika Therapeutics, INC. | $1,200.93 | 2021-2023 | Ovomotion, Actiflip, X-Twist |
| Histosonics, INC. | $1,194.41 | 2025 | |
| Impulse Dynamics (USA) INC. | $241.71 | 2022-2023 | Optimizer |
| Pylant Medical | $156.55 | 2022 | |
| Ortho Development Corporation | $144.61 | 2021 | |
| Zimmer Biomet Holdings, INC. | $137.79 | 2019-2020 | |
| Aesculap Implant Systems, LLC | $134.58 | 2019 | |
| Arthrosurface Incorporated | $97.05 | 2020 | |
| Amgen INC. | $89.80 | 2024 | Krystexxa |
| Parcus Medical, LLC | $88.77 | 2020 | |
| Smith+Nephew, INC. | $75.33 | 2022 | |
| Orthofix Medical, INC. | $52.62 | 2021-2022 | |
| Integra Lifesciences Corporation | $42.95 | 2019 | |
| Depuy Synthes Sales INC. | $15.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Browne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.